Friday, April 22, 2016

Ups and downs; Germany or Sweden

I watched this short video with Dr. Liu today. I thought you may be interested. He is probably the most knowledgeable doctor for NET cancer in the US. He is discussing PRRT which is the treatment I am still considering in Germany. I'm also looking into an immunology clinical trial at Uppsala University in Sweden.
 

I've been suffering with several problems of late and not feeling well. Extremely bad colds and flu bugs have been plaguing me. I seem to catch everything from everyone including the darling grandchildren. I've also had a painful back and what might be sciatica problem on the right side. Its quite bad at night and preventing me from getting good sleep along with the plugged nose and cold symptoms. Frequent urination and dehydration from the diabetes also affects sleep negatively. I always want to remind people I never had diabetes or any blood sugar problems prior to the pancreatic surgery. Alas, I never seem to know what is damage from the surgeries, cancer and/or normal aging. I try to remain up beat but sometimes when I stop doing yoga and walking because I don't feel good, then I also want a cookie or ice cream because I'm feeling a bit sorry for myself and thus you have the downward spiral.
 
As my birthday month of May approaches I will get back into exercising, eating better and spending time in my garden with our beautiful spring. I am constantly reminded of how much I have to be thankful for. Accepting everything as it is and still being grateful feels better than any other alternative. So I sleep, rest up, take care of myself and move forward. All will pass in time.....including all of us. With much love to all of you this spring season, may we all bloom where we're planted and enjoy new growth.

Sunday, March 13, 2016

MRI shows growth in liver tumors

A brief note to say the last 2 MRI's one in September and the other earlier this month show some slight growth in 3 tumors. The other liver tumors have stayed the same size and there have been no new tumors. The recent bone scan showed no growth. Due to the growth in the liver I will step up my plans to pursue the PRRT (PRRT.org) treatment either in Germany or at a clinical trial here in the US. I hope to get into the NYC one I posted about earlier.
Life has been full. Supporting my mom and dad through some health issues, helping to bring my new granddaughter into the world, walking, yoga, spending time with all 4 grandchildren and with friends seem to be enough to keep me busy. Managing my fairly healthy diet takes time too.

Happy Spring and Day Light Savings Day!

One mans story

New post on Carcinoid Cancer Foundation

Trader Joe’s Saved My Life: Steven Muller’s Story

by The Carcinoid Cancer Foundation (CCF)
The combination of a lengthy road-bike ride, a recovery drink mix, and dried figs from Trader Joe’s led to a health crisis for Steven Muller and a subsequent diagnosis of a neuroendocrine tumor (NET) in his small intestine - a rare disease that affects at least 125,000 people in the United States. Steven is sharing his story today, February 29, 2016, Rare Disease Day, in hopes that others who have neuroendocrine tumors get a proper diagnosis, early on.Steven Muller

Neuroendocrine tumor patients often go undiagnosed or misdiagnosed for years. From the initial onset of symptoms the average time to proper diagnosis often exceeds five years.
A seasoned and accomplished athlete, Steven didn’t anticipate how he would feel back in July of 2013 after cycling 60 miles on a very hot day and experiencing a 4,000 foot altitude gain during the ride. He stopped off at the home of Andreas Bibl, the man he describes as his Silicon Valley Mentor, who offered Steven a highly-concentrated drink and dried figs to help him recover from his state of dehydration. One of the figs bloated, got stuck in Steven’s intestines, and caused a small bowel obstruction. That led to an ER visit and an eventual colonoscopy during which doctors discovered the tumor that had been slowly growing for many years. Without that unique confluence of events –especially the Trader Joe’s fig getting stuck on the tumor and literally saving his life – Steven’s cancer would have continued to grow and spread.
At the time doctors diagnosed Steven, his tumor had already spread to 30 lymph nodes and nearby organs. Surgery was scheduled for August. Using da Vinci robotic technology, a minimally invasive procedure during which surgeons operate through a few small incisions, Steven had a right hemicolectomy, an appendectomy, and a right ileocolectomy.
Upon reflection after his diagnosis, Steven realized he actually had symptoms of a neuroendocrine tumor as far back as 10 years prior. He had facial blushing and some unusual bowel habits. Symptoms of gastrointestinal neuroendocrine tumors that are producing excess hormones include flushing and diarrhea, similar to the symptoms of more common illnesses such as Crohn’s disease and irritable bowel syndrome.
“Early detection is critical,” says Steven, advising anyone who suspects a neuroendocrine tumor to “be relentless, go to reputable medical professionals, get all of the necessary tests, and take recommendations of actions as mandatory.”
As he was only 33 when diagnosed, Steven wouldn’t normally have had a colonoscopy. But when his small bowel obstruction resolved itself and the doctor suggested a colonoscopy, Steven scheduled it immediately. Following his diagnosis, he scheduled appointments with 3 different neuroendocrine tumor specialists, two in California and one in New York.
When people look at Steven they see a young, healthy, fit man. “Just because you look a certain way doesn’t mean you’re healthy,” says Steven. In addition to his NET diagnosis, he learned in 2014 that he had basal cell skin cancer on his face, near his sideburn. Moh’s surgery was used to remove the small growth, which he had thought was a mole and was discovered by a dermatologist who was checking out a mole on Steven’s back that was irritating when he exercised.
As the 36-year-old father of 3 young girls, ages 5, 3, and 9 months, Steven has reflected upon what cancer might mean in his life. He is vigilant in visiting doctors to ensure he is properly followed and he is very optimistic about his future. His diagnosis initially caused him great anxiety and high blood pressure. His doctor recommended cognitive behavioral therapy at Stanford University in California which helped Steven to feel better prepared to handle the stresses of living with a cancer diagnosis.
Steven and Jackie Muller and their 3 daughters.
Steven and Jackie Muller and their 3 daughters.
Steven also worked longer hours to shift his focus and he believes that immersing himself in his work was helpful. One of the Heads of Business Development for Google Play App Developers in California, Steven made his way to Silicon Valley from the East Coast. He grew up in the northern suburbs of New Jersey, went to parochial school, became a state champion wrestler and pole vaulter, and was eventually nominated to the United States Naval Academy in Annapolis, Maryland.
After earning his Bachelor of Science in Economics from the Naval Academy, he was accepted into the highly competitive Naval Nuclear Submarine Officer program and received the equivalent of a Master of Engineering Management in conjunction with Nuclear Power training. He served as a Division Officer on board a Ballistic Nuclear Submarine (USS West Virginia, SSBN 736) and received a Top Secret Security clearance, during which time he managed a nuclear reactor plant, operated a periscope, and broke top secret codes while transiting hundreds of feet below the surface of the ocean. He chose this path following high school, says Steven, because “I wanted to serve my country and do it in a way that was fun and exciting.”
Realizing he didn’t want to make the Navy his long-term career, Steven then transitioned into banking and went to work on Wall Street in derivatives, first with Barclays Capital and then serving as Vice President of Financial Operations at Deutsche Bank.
When the financial crisis of 2007-2008 struck Steven chose to pursue a new path. He earned a Master of Business Administration (MBA) from Duke University in North Carolina and from there he moved to the West Coast. He began the next phase of his career at Google, first as Finance Manager, working on a strategic payment solution for Google Shopping and spearheading major strategic divestiture, and most recently with Google’s Strategic Account Management for Google Play. “Google is a company that appreciates innovative thinking,” says Steven. It is that culture that makes him thrive personally and professionally and has earned him awards for leadership and high levels of accomplishment.
Always attracted to that which is highly challenging and difficult has guided Steven from his youth on, whether it is in athletics, Armed Forces service, banking, or management. His ultimate career objective is to be a Chief Operating (or Business) Officer of a major organization that focuses on making the world a better place.
Steven has also dedicated himself to cycling, doing 100 mile rides each year, including an annual ride in the Best Buddies Challenge: Hearst Castle, raising funds for Best Buddies programs for inclusion for people with intellectual and developmental disabilities.
That’s where Steven’s mentor and friend, Andreas Bibl, inventor and entrepreneur, comes in. It was Andreas who encouraged and inspired Steven to become an avid cyclist in 2011 and pushed him to ride the Tunitas Creek route on July 13, 2013. And it was at Andreas’ house where they stopped to eat Trader Joe’s figs while drinking Cytomax. Andreas himself was diagnosed with cancer 6 months after Steven and they fought cancer together, riding the rigorous hills and roads of Silicon Valley.
Steven Muller (right) and Andreas Bibl (left)
Andreas Bibl (left) and Steven Muller (right)
Interaction with family and friends led Steven on the path to acceptance of his cancer. It has been a demanding journey since he initially learned of his diagnosis – in fact his ears were ringing so loudly when the doctor said the words Stage IV cancer that he could not hear anything else at the time. But he has come to accept his journey as he has all of the other challenges in his life. With loving support from his wife, Jackie; the pride and joy he takes in his three daughters; mentorship from his Silicon Valley friend Andreas; and the wonderful team of people at Google, Steven continues to seek out and embrace new challenges and new opportunities.


Thursday, March 10, 2016

Applying to new Clinical Trial in NYC

A Study to Assess the Use of Radiolabeled DOTA-JR11 to Diagnose and Treat Neuroendocrine Tumors

         

Full Title

Theranostics of Radiolabeled Somatostatin Antagonists 68Ga-DOTA-JR11 and 177Lu-DOTA-JR11 in Patients with Neuroendocrine Tumors

Purpose

The purpose of this study is to assess the use of a peptide called DOTA-JR11 to locate and treat metastatic or inoperable neuroendocrine tumors. DOTA-JR11 is similar to a natural hormone called somatostatin. Receptors for somatostatin are commonly found on the surface of neuroendocrine tumors.
In the first part of this study, DOTA-JR11 will be attached to a radioactive substance called gallium-68 and will be given to patients intravenously (by vein). Through PET scanning, researchers can see where the DOTA-JR11 binds, indicating a tumor contains somatostatin receptors. The gallium-68 makes the location of these receptors visible on the PET scan.
In the second part of the study, researchers will attach radioactive lutetium-177 to DOTA-JR11. DOTA-JR11 will bind to a patient's tumor cells in the same way as gallium-68 DOTA-JR11, and it is hoped that the radiation from lutetium-177 will kill those cells. In this part of the study, researchers will determine the safe dose of lutetium-labeled DOTA-JR11 and also examine the drug's effectiveness for treating neuroendocrine tumors.

Eligibility

To be eligible for this study, patients must meet several criteria, including but not limited to the following:
  • Patients must have a carcinoid or pancreatic neuroendocrine tumor that is metastatic or inoperable.
  • At least 4 weeks must pass between the completion of chemotherapy and 6 weeks since local therapies and entry into the study.
  • Patients may not have previously received prior radiolabeled therapy (including SIRTs).
  • Patients' blood counts must be within normal limits.
  • Patients must be able to be walk and do routine activities for more than half of their normal waking hours.
  • This study is for patients age 18 and older.
For more information about this study and to inquire about eligibility, please contact Dr. Wolfgang Weber at 212-639-7373 or Dr. Diane Reidy-Lagunes at 646-888-4185.

Protocol

15-161

Phase

Pilot

Disease Status

Relapsed or Refractory

Investigator

Locations